Emerald Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Emerald Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-700,046	Closed	-$27.5M	–	248
2023 Q2	$27.5M	Sell	700,046 -53,986	-7%	-$1.91M	1.2%	20
2023 Q1	$18.3M	Sell	754,032 -6,012	-0.8%	-$132K	0.88%	44
2022 Q4	$16.3M	Sell	760,044 -202,863	-21%	-$4.33M	0.79%	57
2022 Q3	$17.3M	Buy	+962,907	New	+$12.6M	0.89%	47

Emerald Advisers's ISEE Position: Q3 2023 in Review

Emerald Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 700,046 shares — an estimated $27.5M sold.

Emerald Advisers first reported a position in ISEE in Q3 2022 and held it in 4 quarters. The position peaked at $27.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Emerald Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Emerald Advisers sold 700,046 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $27.5M.
Emerald Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Emerald Advisers's IVERIC bio, Inc. Common Stock position peaked at $27.5M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.